|
The analysis examines
data from June through September from Epic’s Cosmos research platform,
which includes data for more than 120,000 hospitalizations with a COVID
diagnosis during the four-month period. Patients are considered “fully
vaccinated” if they received a dose of Johnson & Johnson vaccine or
two doses of the Pfizer or Moderna vaccine at least two weeks before they
were hospitalized, regardless of whether they were eligible for or
received a booster shot.
Compared to those who are unvaccinated, a small share (15%) of hospital
admissions for COVID-19 during the four-month period involve people who
were fully vaccinated against the disease.
Other findings include:
- Larger
shares of fully vaccinated adults hospitalized with breakthrough
COVID-19 had selected chronic conditions including hypertension,
diabetes, heart failure, or chronic obstructive pulmonary disease
compared to those hospitalized with COVID-19 who were not fully
vaccinated.
- Fully
vaccinated people who are hospitalized with breakthrough COVID-19
are less likely than those who are not fully vaccinated to have
COVID-related complications such as viral pneumonia or respiratory
failure, or to receive a ventilator or dexamethasone treatment. This
suggests that fully vaccinated patients with COVID-19 diagnoses may
be somewhat more likely to be in the hospital primarily for reasons
other than COVID-19.
- Fully
vaccinated people with breakthrough infections had shorter hospital
stays compared to others in their age group who were not fully vaccinated.
For example, among those at least 65 years old with COVID-19, the
median stay was 5.6 days for those who were fully vaccinated
compared to 6.7 days for those who were unvaccinated or partly
vaccinated.
The analysis is
available on the Peterson-KFF
Health System Tracker, an online information hub dedicated to
monitoring and assessing the performance of the U.S. health system.
|
No comments:
Post a Comment